Multi-centre study of the in vitro activity of ceftolozane/tazobactam and other commonly used antibiotics against Pseudomonas aeruginosa isolates from patients in the United Kingdom (INVICTUS)

20/04/2018
14/03/2024
EU PAS number:
EUPAS23451
Study
Ongoing
Documents
Study protocol
Initial protocol
English (2.06 MB - PDF) View document
Study results
Study report
Other information